Sucampo licenses lubiprostone to Abbott Japan »
Posted By poolk_123 9 months, 1 week ago in Science & TechnologyThe subsidiary of US-based Sucampo Pharmaceuticals has entered into a license and commercialization agreement with Abbott Japan for Sucampo’s lubiprostone (Amitiza) in Japan.
Read Full Story at biospectrumasia.com »
29 Views Share Story 0 Comments Report
Other Related Articles: All »
More News
Download Squad
Airlock: auto-lock your Mac, unlock it with your iPhone or iPod Touch
VLC creators working on a cross-platform video editing app
Potion Panic: lob alchemical concoctions at nasty beasties - Time Waster
Pingdom Desktop Notifier tells you when your web site goes down
AverMedia launches SnugTV: Stream Live TV to any PC over the web
Engadget
San Francisco considers displaying phone radiation levels next to price tag
Researchers receive grant to develop color-changing contacts for diabetics
HDMI 1.4 spec getting freshened up in preparation for broadcast 3D
Amazon Kindle gets its DRM stripped (for the time being)
FCC commish says Verizon's ETF response is 'unsatisfying and, in some cases, troubling'
Add a Comment
Sign In With Your Propeller Account
Please keep your comments relevant to this story.
To create a live link, simply type the URL (including http://) or email address and we will make it a live link for you. You can put up to 3 URLs in your comments. Line breaks and paragraphs are automatically converted — no need to use <p> or <br /> tags.